Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Sequencing Hub Using Life Tech Instruments

NEW YORK (GenomeWeb News) – Life Technologies said today that it has formed a translational research collaboration with the University of Cambridge that will enable researchers to use the firm’s sequencing technologies through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

Under the collaboration, European researchers studying cancer, diabetes, and other disorders will be able to use three SOLiD 3 Plus Systems for next generation targeted resequencing and whole transcriptome analysis studies.

The sequencing hub at Cambridge was funded by the UK’s Medical Research Council, the National Institute for Health Research, and the University’s Clinical School. Its mission is to help scientists use genetic information to develop new treatments, diagnostics, and prevention strategies for major diseases.

Cambridge Professor John Todd said in a statement that the sequencing tools will provide researchers with “the throughput and accuracy required for comprehensive characterization of disease programs.

“The translation of this information into clinically relevant knowledge will have a direct impact on the treatment of human disease through the development of better diagnostic, prognostic, and therapeutic agents," Todd added.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.